Neurocognitive deficits seen in HIV-associated neurocognitive disorders (HANDs) are attributed to the release of soluble factors from CNS-resident, HIV-infected and/or activated macrophages and microglia. To study HIV-associated neurotoxicity, we used our in vitro model in which primary rat neuronal/glial cultures are treated with supernatants from cultured human monocyte-derived macrophages, infected with a CNS-isolated HIV-1 strain (HIV-MDM). We found that neuronal damage, detected as a loss of microtubule-associated protein-2 (MAP2), begins as early as 2 h and is preceded by a loss of mitochondrial membrane potential ( m ). Interestingly, inhibitors of calpains, but not inhibitors of caspases, blocked MAP2 loss, however neither type of inhibitor prevented the loss of m . To facilitate throughput for these studies, we refined a MAP2 cell-based-ELISA whose data closely compare with our standardized method of hand counting neurons. In addition, we developed a tetramethyl rhodamine methyl ester (TMRM)-based multi-well fluorescent plate assay for the evaluation of whole culture m . Together, these findings indicate that calpain activation and loss of m may be parallel pathways to death in HIV-MDM-treated neurons and also demonstrate the validity of plate assays for assessing multiple experimental parameters as is useful for screening neurotherapeutics for neuronal damage and death.
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Introduction
It is estimated that HIV-associated neurocognitive disorders (HANDs) continue to affect up to 50% of the HIV-positive population despite the introduction of combination antiretroviral therapies over a decade ago (Boisse et al., 2008; Brew et al., 2008; Ellis et al., 2007; Robertson et al., 2007; Tozzi et al., 2005) . Although damage and loss of neurons are the primary pathologic correlates of neurocognitive deficits in HAD, little evidence supports productive viral infection of neurons in vivo (Gonzalez-Scarano and Martin-Garcia, 2005). Instead, two mechanisms of damage have been proposed, one or both of which may cause neurodegeneration in this disease: (1) damage is mediated by neurotoxic viral proteins and/or (2) damage is cause by neurotoxic factors (e.g. metabolites, cytokines, etc.) released as part of the concurrent perivascular inflammatory response that occurs near the regions of HIV entry into the brain. We and others have previously described in vitro models to test the hypothesis that activated brain macrophages secrete soluble factors that can mediate neuronal damage (Jiang et al., 2001; O'Donnell et al., 2006 ). In our model, supernatants from HIV-infected, monocyte-derived macrophages (HIV-MDM) are collected at the time of peak infection and applied to 2-3-week-old primary rat hippocampal or cortical cultures for a 24 h period. Treatment with HIV-MDM results in an NMDA receptor-dependent neuronal loss that is mediated by heat-and protease-resistant soluble excitotoxins under 3 kDa in size (O'Donnell et al., 2006) . During classic NMDA receptor-mediated excitotoxic insults, cytoplasmic levels of Ca 2+ are increased through activated ion channels (Choi, 1994) . The influx of Ca 2+ that occurs with these insults can result in depolarization of mitochondrial membrane potential ( m ) and mitochondrial dysfunction, ultimately contributing to neuronal damage and death (Brookes et al., 2004; Duchen, 2000; Gunter et al., 1994; Keelan et al., 1999; Khodorov et al., 1996; Schinder et al., 1996) . Additionally, increased levels of Ca 2+ can also directly activate cell-death proteases, such as the Ca 2+ dependent protease, calpain, or caspases (Foos and Wu, 2002; Tian et al., 2008) . Galicia et al. (2002) have suggested that increased cytoplasmic Ca 2+ may play a role in neuronal death in HAD.
